Puma Biotechnology, Inc. ( PBYI) - Key Metrics
PBYI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.50 | $0.27 | $0.42 | $0.42 |
| 2025Q3 | $1.08 | $0.18 | $0.19 | $0.19 |
| 2025Q2 | $1.06 | $0.12 | $0.28 | $0.28 |
| 2025Q1 | $0.93 | $0.06 | $0.07 | $0.07 |
PBYI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 5.59 |
| 2025Q3 | ? | 7.56 |
| 2025Q2 | ? | 7.28 |
| 2025Q1 | ? | 12.34 |
PBYI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 4.74% | ? |
| 2025Q4 | 4.83% | ? |
| 2025Q3 | 3.62% | ? |
| 2025Q2 | 8.25% | ? |
| 2025Q1 | 2.42% | ? |
PBYI
Price: $6.81
52 week price:
Earnings Per Share: 0.48 USD
P/E Ratio: 14.94
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 234700
Ebitda: -76.5 millionMarket Capitalization: 364.9 million